Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutations
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-020-06084-5.pdf
Reference17 articles.
1. Cott CV (2020) Cancer genetics. Surg Clin 100:483–498. https://doi.org/10.1016/j.suc.2020.02.012
2. Yoshida R (2020) Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer. https://doi.org/10.1007/s12282-020-01148-2
3. Correa H (2016) Li–Fraumeni syndrome. J Pediatr Genet 5:84–88. https://doi.org/10.1055/s-0036-1579759
4. Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185–187. https://doi.org/10.1038/ng1096-185
5. Pinto EM, Zambetti GP (2020) What 20 years of research has taught us about the TP53 p. R337H mutation. Cancer 126:4678–4686. https://doi.org/10.1002/cncr.33143
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2;Cancers;2023-12-06
2. Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family;Cancer Genetics;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3